TREM2 and amyloidosis: In the PS19 model, deletion of TREM2 resulted in significantly less brain atrophy and ameliorated the microgliosis phenotype [27]; by contrast, in the 5xFAD model, TREM2 deficiency exacerbated amyloidosis and neuronal loss [28].